Interaction Checker

Famciclovir : interactions médicamenteuses

Famciclovir (Famvir), antiviral, présente 66 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 0 de niveau majeur, 4 de niveau modéré, 43 de niveau mineur et 19 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

Interactions d'après la notice

Interactions modérées (4)

  • Digoxineglycoside digitaliqueModérée

    Potential for Famciclovir to Affect Other Drugs The steady-state pharmacokinetics of digoxin were not altered by concomitant administration of multiple doses of famciclovir (500 mg three times daily). (notice Famciclovir, Interactions médicamenteuses)

  • ProbénécideModérée

    Probenecid: May increase penciclovir levels. (notice Famciclovir, Interactions médicamenteuses)

  • Probénécide et colchicineModérée

    Probenecid: May increase penciclovir levels. (notice Famciclovir, Interactions médicamenteuses)

  • Raloxifènemodulateur sélectif des récepteurs aux estrogènesModérée

    Raloxifene, a potent aldehyde oxidase inhibitor in vitro , could decrease the formation of penciclovir. (notice Famciclovir, Interactions médicamenteuses)

Mentions mineures (43)

  • AmiodaroneantiarythmiqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Aprépitantinhibiteur du CYP3A4Mineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • AtazanavirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • CénobamateanticonvulsivantMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • CiclosporineimmunosuppresseurMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Cimétidineantihistaminique H2Mineure

    Clinical interaction studies of famciclovir with cimetidine and promethazine, in vitro inhibitors of aldehyde oxidase, did not show relevant effects on the formation of penciclovir. (notice Famciclovir, Interactions médicamenteuses)

  • Clarithromycineantibiotique macrolideMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • DarunavirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Darunavir et cobicistatantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Diltiazeminhibiteur calciqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • DronédaroneantiarythmiqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • ÉfavirenzantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Éfavirenz, lamivudine et ténofovirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Elvitégravir, cobicistat, emtricitabine et ténofovirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • EmtricitabineantirétroviralMineure

    The potential for drug interactions with EMTRIVA has been studied in combination with AZT, indinavir, d4T, famciclovir, and tenofovir DF (TDF). (notice Emtricitabine, Interactions médicamenteuses)

  • Érythromycineantibiotique macrolideMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • ÉvérolimusimmunosuppresseurMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Fluconazoleantifongique azoléMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • FosamprénavirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Fosaprépitantinhibiteur du CYP3A4Mineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Imatinibinhibiteur du CYP3A4Mineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • IsoniazideantibiotiqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Itraconazoleantifongique azoléMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Ivacaftorinhibiteur du CYP3A4Mineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Kétoconazoleantifongique azoléMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • LénacapavirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Lopinavir et ritonavirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Mifépristoneinhibiteur du CYP3A4Mineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Mirabégronagoniste bêta-adrénergiqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • NéfazodoneantidépresseurMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Nirmatrelvir et ritonavirantiviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Palbociclibinhibiteur du CYP3A4Mineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • PérampanelanticonvulsivantMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Posaconazoleantifongique azoléMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • ProméthazineantihistaminiqueMineure

    Clinical interaction studies of famciclovir with cimetidine and promethazine, in vitro inhibitors of aldehyde oxidase, did not show relevant effects on the formation of penciclovir. (notice Famciclovir, Interactions médicamenteuses)

  • Prométhazine et codéineopioïdeMineure

    Clinical interaction studies of famciclovir with cimetidine and promethazine, in vitro inhibitors of aldehyde oxidase, did not show relevant effects on the formation of penciclovir. (notice Famciclovir, Interactions médicamenteuses)

  • Prométhazine et dextrométhorphaneantihistaminiqueMineure

    Clinical interaction studies of famciclovir with cimetidine and promethazine, in vitro inhibitors of aldehyde oxidase, did not show relevant effects on the formation of penciclovir. (notice Famciclovir, Interactions médicamenteuses)

  • Ranolazinemédicament allongeant l'intervalle QTMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • RitonavirantirétroviralMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Suvorexantsédatif-hypnotiqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Ticagrélorantiagrégant plaquettaireMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Vérapamilinhibiteur calciqueMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

  • Voriconazoleantifongique azoléMineure

    An in vitro study using human liver microsomes suggests that famciclovir is not an inhibitor of CYP3A4 enzymes. (notice Famciclovir, Interactions médicamenteuses)

Aucune interaction significative signalée (19)

  • Allopurinolinhibiteur de la xanthine oxydaseAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • AminophyllineméthylxanthineAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Antiacides (Tums, Maalox, Mylanta)Produits sans ordonnanceAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Bicarbonate de sodiumantiacideAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Bictégravir, emtricitabine et ténofovir alafénamideantirétroviralAucune interaction

    No clinically significant effect on the pharmacokinetics of zidovudine, its metabolite zidovudine glucuronide, or emtricitabine was observed following a single oral dose of 500 mg famciclovir coadministered with zidovudine or emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Butalbital, aspirine et caféinebarbituriqueAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Butalbital, aspirine, caféine et codéinebarbituriqueAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Butalbital, paracétamol et caféinebarbituriqueAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Butalbital, paracétamol, caféine et codéinebarbituriqueAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Emtricitabine et ténofovirantirétroviralAucune interaction

    No clinically significant effect on the pharmacokinetics of zidovudine, its metabolite zidovudine glucuronide, or emtricitabine was observed following a single oral dose of 500 mg famciclovir coadministered with zidovudine or emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Emtricitabine, rilpivirine et ténofovirantirétroviralAucune interaction

    No clinically significant effect on the pharmacokinetics of zidovudine, its metabolite zidovudine glucuronide, or emtricitabine was observed following a single oral dose of 500 mg famciclovir coadministered with zidovudine or emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Ergotamine et caféinealcaloïde de l'ergot de seigleAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Fébuxostatinhibiteur de la xanthine oxydaseAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Lamivudine et zidovudineantirétroviralAucune interaction

    No clinically significant effect on the pharmacokinetics of zidovudine, its metabolite zidovudine glucuronide, or emtricitabine was observed following a single oral dose of 500 mg famciclovir coadministered with zidovudine or emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Oméprazole et bicarbonate de sodiuminhibiteur de la pompe à protons (IPP)Aucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • Orphénadrine, aspirine et caféinemyorelaxantAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • PentoxifyllineméthylxanthineAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • ThéophyllineméthylxanthineAucune interaction

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

  • ZidovudineantirétroviralAucune interaction

    No clinically significant effect on the pharmacokinetics of zidovudine, its metabolite zidovudine glucuronide, or emtricitabine was observed following a single oral dose of 500 mg famciclovir coadministered with zidovudine or emtricitabine. (notice Famciclovir, Interactions médicamenteuses)

Vérifiez Famciclovir avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.